CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -928.4% | -463.5% | -801.4% | -3,887.8% | -87,362.0% | -8,217.8% | -2,432.0% | -4,144.2% | -21,748.8% | -4,910.6% | |
| 15.6% | 6.3% | 19.4% | 74.4% | 1,335.2% | 85.5% | 20.8% | 27.4% | 268.0% | 50.5% | |
| 45.8% | 13.3% | 95.6% | 527.6% | 14,685.9% | 1,609.6% | 596.7% | 1,020.1% | 6,678.2% | 1,182.7% | |
| 45.8% | 13.3% | 77.7% | 527.2% | 14,733.8% | 1,580.2% | 614.7% | – | – | – | |
| 32.1% | -35.3% | 218.2% | -178.8% | 529.6% | 101.7% | 392.9% | 200.4% | 1,119.8% | 62.9% | |
| 32.3% | 14.9% | 43.6% | 41.2% | 262.0% | 40.4% | 35.0% | 116.8% | 370.0% | 74.9% | |
| -32.3% | -14.9% | -4,920.0% | 3,492.6% | 305.6% | -5,239.6% | -3,672.8% | -4,994.1% | -55,324.1% | 2,259.7% | |
| -0.8% | 588.5% | 7,009.8% | -4.9% | 161,367.6% | 0.0% | – | -13.5% | -1,442.0% | 0.0% | |
| -8.1% | -10.4% | – | – | – | – | – | – | – | – | |
| -9.0% | 578.1% | 7,009.8% | 5.6% | 161,367.6% | 23,439.6% | 2,574.7% | 9,692.1% | 97,250.7% | 527.7% | |
| -969.6% | 99.8% | 1,288.3% | -389.5% | 74,311.3% | 9,982.2% | -3,530.1% | 553.8% | 20,177.9% | -2,124.6% | |
| -960.6% | -478.4% | -845.1% | -3,929.0% | -87,623.9% | -8,258.3% | -2,467.0% | -4,261.0% | -22,118.8% | -4,985.5% |
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.